Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.
scientific article published on 28 March 2016
Author/s
author: Prudence Francis, Eva M Ciruelos, Ana Lluch, Fabio Puglisi, Marco Colleoni, Patrick Neven, Harold J. Burstein, Aron Goldhirsch, Meredith M Regan, Karin Ribi, Gini F. Fleming, Carlo Tondini, Thomas Ruhstaller, Karen L Price, Weixiu Luo, Lorenzo Pavesi, Vani Parmar, Meritxell Bellet, Antonia Perelló, Arvid Carlsson
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.